No clinically important variances in the pharmacokinetics of midazolam (CYP3A4 substrate) or its metabolite one-hydroxymidazolam were observed when utilised concomitantly with single or multiple doses of lumateperone in individuals with schizophrenia.The brand new neural pathways—think of them as new streets in your Mind—help you generate addit